Aveanna Healthcare Holdings Inc.
$7.94
The Read: Aveanna’s stock fell sharply on Q4 2025 results missing margin expansion and acquisition debt concerns, then rallied on a Q4 earnings beat despite cautious 2026 revenue guidance, gained modestly after favorable CMS rate news, stayed flat on in-line Q1 2026 EPS amid steady labor conditions, and surged following strong Q1 revenue growth and raised guidance driven by better reimbursements and efficiencies.
Price
Overlays
Panel
AVAH
Hover to view data
No Data